SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma

Condition:   Head and Neck Squamous Cell Carcinoma Intervention:   Drug: Anti-EGFR monoclonal antibody Sponsor:   Shi Yuankai Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials